|4May 30, 4:08 PM ET

MANHARD KIMBERLY 4

4 · Inhibrx, Inc. · Filed May 30, 2023

Insider Transaction Report

Form 4
Period: 2023-05-25
Transactions
  • Award

    Stock Option (right to buy)

    2023-05-25+15,00015,000 total
    Exercise: $23.03Exp: 2033-05-25Common Stock (15,000 underlying)
Footnotes (1)
  • [F1]Twenty-five percent (25%) of the total shares subject to the stock option become exercisable on May 25, 2024, with the balance to vest and become exercisable in equal successive monthly installments for thirty-six (36) months thereafter.

Documents

1 file
  • 4
    wk-form4_1685477312.xmlPrimary

    FORM 4